|
Bell KJ, Saad S, Tillett BJ, McGuire HM, Bordbar S, Yap YA, Nguyen LT, Wilkins MR, Corley S, Brodie S, Duong S, Wright CJ, Twigg S, de St Groth BF, Harrison LC, Mackay CR, Gurzov EN, Hamilton-Williams EE, Marino E. Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation. Microbiome. 2022 Jan 19;10(1):9. doi: 10.1186/s40168-021-01193-9. PubMed PMID: 35045871; PubMed Central PMCID: PMC8772108.
AÑO: 2022; IF: 15.5
|
35045871